Opportunity
DIBBS #SPE2DP-27-T-0079
DLA procurement of 60 bottles of moxifloxacin hydrochloride tablets
Posted
October 09, 2026
Respond By
October 14, 2026
Identifier
SPE2DP-27-T-0079
NAICS
424210, 325412
DLA Troop Support is seeking moxifloxacin hydrochloride tablets for military medical supply needs. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA; contracting contact: Nicholas Quigley. - Product and quantity: 60 bottles total of moxifloxacin hydrochloride 400 mg tablets, 30 tablets per bottle; NSN 6505-01-503-4772. The seven order quantities are 5, 10, 1, 5, 12, 12, and 15 bottles. - Named OEMs / approved sources: Teva Pharmaceuticals USA, Inc. (NDC 00093-7387-56) and Rising Pharma Holdings, Inc. (NDC 57237-0156-30). - Delivery and handling: Delivery is required within 5 days after order for multiple Navy vessels and a Fort Hood unit. The FDA-regulated product must be stored at controlled room temperature, protected from high humidity, and supplied with a 36-month, non-extendable shelf life.
Description
MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7017192160) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 10, NSN: 6505-01-503-4772, Purchase Request: 7017651238) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7017383383) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7016833667) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7016895121) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7017319340) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 15, NSN: 6505-01-503-4772, Purchase Request: 7017190258) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.